ZEOX— Zeo ScientifiX, Inc.

$11M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenues (includes sales to related parties of approximately $88,000 and $199,000, respectively)	$5.2M+12.5%	$4.6M+1.4%	$4.6M-29.8%	$6.5M
Cost of revenues	$931K+10.3%	$844K+66.1%	$508K-32.6%	$754K
Gross profit	$4.3M+13.0%	$3.8M-6.8%	$4.0M-29.4%	$5.7M
General and administrative expenses	$9.7M+6.1%	$9.1M-15.9%	$10.8M-25.8%	$14.6M
Loss from operations	-$5.4M-1.3%	-$5.3M+21.4%	-$6.8M+23.5%	-$8.8M
Interest expense	-$98K-6.5%	-$92K+78.7%	-$431K-8.2%	-$398K
Change in obligation to repurchase shares	-$2K	—	—	—
Inducement expense to convert Notes in payable	-$136K	—	—	—
Impairment of non-marketable securities in a related entity	-$45K	—	-$100K	—
Other income	$101K-86.6%	$751K+7610.0%	-$10K-104.0%	$250K
Net loss	-$5.5M-17.3%	-$4.7M+32.7%	-$7.0M+21.5%	-$8.9M
Net loss per common share - basic	-$0.86-16.2%	-$0.74+25.3%	-$0.99+36.5%	-$1.56
Net loss per common share - diluted	-$0.86-16.2%	-$0.74+25.3%	-$0.99+36.5%	-$1.56
Weighted average number of common shares outstanding - basic	6.4M+1.2%	6.3M-9.8%	7.0M+23.6%	5.7M
Weighted average number of common shares outstanding - diluted	6.4M+1.2%	6.3M-9.8%	7.0M+23.6%	5.7M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 11 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.